Skip to content

Investigating the effect of oral capsules containing hydroalcoholic extract of Rosa damascena petals on bowel function after cesarean section

Investigating the effectiveness of administering oral capsules containing hydroalcoholic extract of Rosa damascena compared to routine care on bowel function after cesarean section in women who have undergone cesarean section.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250629066297N1
Enrollment
88
Registered
2025-08-03
Start date
2025-06-29
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: complications of the puerperium. Condition 2: functional intestinal disorders. Other complications of the puerperium, not elsewhere classified Other specified functional intestinal disorders

Interventions

Intervention 1: Intervention group: Receive capsules containing hydroalcoholic extract of rose petals. Oral capsule containing rose extract: First, rose petals are prepared and approved by a herbalist

Sponsors

Yasouj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age between 18-45 years Candidate for elective cesarean section with local spinal anesthesia Fasting for at least 8 hours before cesarean section surgery Cooperation and consent to participate in the study Signing a written informed consent form Gestational age 38 to 42 weeks Good vital signs in mother and baby (maternal vital signs within normal limits and infant signs within normal limits for the infant)

Exclusion criteria

Exclusion criteria: Use of anticoagulant drugs Use of painkillers and sedatives Unusual complications during surgery Having medical or gynecological disorders, such as hypothyroidism, diabetes, or neuromuscular disorders History of irritable bowel syndrome and idiopathic constipation Diarrhea, vomiting, or bloating in the past 48 hours Patients with postoperative complications such as uterine atony Patients with intraoperative complications (severe adhesions, excessive bowel manipulation, excessive blood loss or transfusion, and damage to the bowel or bladder) Patients whose surgery lasts more than 90 minutes Those who receive heavy doses of sedation during surgery Cesarean section above four

Design outcomes

Primary

MeasureTime frame
Time interval from first bowel movement to cesarean section. Timepoint: From four hours after the cesarean section, every hour until 24 hours after the cesarean section. Method of measurement: All patients were asked to record the time of their first bowel movement and report it to the researcher or record it on the postoperative evaluation form.;The interval between the first gas release and the time of cesarean section. Timepoint: From four hours after the cesarean section, every hour until 24 hours after the cesarean section. Method of measurement: All patients were asked to record the time of the first gas release and inform the researcher.;Time interval from the time of first bowel sound to cesarean section. Timepoint: Information regarding the first hour of bowel sound auscultation is reviewed and recorded by the researcher every hour until the sound is auscultated. Method of measurement: Information regarding the first hour of bowel sound auscultation is reviewed and recorded by the researcher every hour until the sound is auscultated.

Secondary

MeasureTime frame
Length of hospital stay. Timepoint: Length of hospital stay after cesarean section in hours. Method of measurement: From the time of cesarean section to discharge in hours.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Tavakoli

Yasouj University of Medical Sciences

Tavakoli.nasrin.2015@gmail.com+98 31 3339 1943

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026